An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease

NCT01118325 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Stable Coronary Artery Disease

Interventions

DRUG: ticagrelor
DRUG: clopidogrel

Sponsor

AstraZeneca